Replicel Life Sciences Inc.
Other Technology · Vancouver Bc, British Columbia, Canada
Replicel Life Sciences Inc. is a other technology company based in Vancouver Bc, British Columbia, Canada. It has raised at least $5.8 million across 20 known rounds, of which $4.9 million was reported to the SEC on 20 Form D filings, most recently in 2024.
RepliCel is a regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2024-12-16 | — | $224K | $5.8M | SEC Form D | |
| 2023-03-16 | — | $741K | $5.6M | SEC Form D | |
| 2023-02-08 | — | $9K | $4.8M | SEC Form D | |
| 2023-01-26 | — | $87K | $4.8M | SEC Form D | |
| 2023-01-06 | — | $559K | $4.8M | SEC Form D | |
| 2022-05-10 | — | $593K | $4.2M | SEC Form D | |
| 2021-12-20 | — | $778K | $3.6M | SEC Form D | |
| 2021-06-03 | —+1 amd | $162K | $2.8M | SEC Form D | |
| 2021-05-27 | — | $9K | $2.7M | SEC Form D | |
| 2021-02-26 | — | $386K | $2.7M | SEC Form D | |
| 2020-08-20 | — | $118K | $2.3M | SEC Form D | |
| 2020-07-24 | — | $447K | $2.1M | SEC Form D | |
| 2019-11-04 | — | $135K | $1.7M | SEC Form D | |
| 2019-09-13 | — | $76K | $1.6M | SEC Form D | |
| 2019-01-22 | — | $21K | $1.5M | SEC Form D | |
| 2017-10-26 | — | $267K | $1.5M | SEC Form D | |
| 2017-01-09 | — | $9K | $1.2M | SEC Form D | |
| 2016-11-08 | — | $112K | $1.2M | SEC Form D | |
| 2015-07-06 | — | $143K | $1.1M | SEC Form D | |
| 2013-04-19 | — | $70K | $938K | SEC Form D | |
| 2012-05-24 | — | $245 | $867K | SEC Form D | |
| 2012-04-25 | — | $594K | $867K | SEC Form D | |
| 2012-04-04 | — | $273K | $273K | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.